Cachexia, and Not Obesity, Prior to Pancreatic Cancer Diagnosis Worsens Survival and is Negated by Chemotherapy

Newsfeed Image, Light Gray Text On Dark Gray Background
Although advanced pancreatic ductal adenocarcinoma (PDAC) is characterized by progressive weight loss and nutritional deterioration, the effect of cancer cachexia and body mass index (BMI) at diagnosis on survival remains unclear.
                                                                                                                                                                                                                                      We retrospectively evaluated a prospectively collected internal cancer registry of PDAC cases from 2006–2014 at the Kaiser Permanente Medical Center. Read more . . .

image_printPrint Page